latest news releases from the newsroom
Immunomedics Reports Results That Could Expand Use of Milatuzumab in Cancer Therapy
DENVER, April 22, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported results presented at the 100th annual meeting of the American Association for Cancer Research (AACR) that indicate CD74 is expressed at high levels in the majority of gastrointestinal tumors, which may allow milatuzumab, the Company's proprietary humanized anti-CD74 antibody, to be used as a therapy for gastrointestinal cancers, either on its own or conjugated with drugs or toxins.
Techwell, Inc. To Host First Quarter 2009 Financial Results Conference Call
SAN JOSE, Calif., April 22, 2009 (GLOBE NEWSWIRE) -- Techwell, Inc. (Nasdaq:TWLL), a leading designer of mixed signal video semiconductor solutions for the security surveillance and automotive infotainment markets, today announced it will release its first quarter of 2009 financial results for the period ending March 31, 2009 on Thursday, April 30, 2009, after the market closes. Following the release, the Company will host a live audio Web cast and conference call beginning at 5:15 p.m. Eastern Time.